Novartis | Kontanter Og Tilsvarende

Cash And Equivalent Lave om Dato
AbbVie USD 13.29B 4.53B 2023-09
Alcon AG USD 1.05B 390M 2023-09
Almirall EUR 226.71M 21.67M 2023-06
Amgen USD 10.94B 23.8B 2023-12
AstraZeneca USD 4.87B 793M 2023-09
Bayer EUR 6.82B 2.33B 2023-09
Eli Lilly USD 2.38B 313.7M 2023-09
Fresenius Medical Care EUR 1.27B 160.23M 2022-12
Genmab DKK 14.27B 3.4B 2023-09
Gilead Sciences USD 8.43B 2.72B 2023-12
GlaxoSmithKline GBP 3.18B 37M 2023-09
GRIFOLS EUR 529.58M 45.35M 2023-12
Hikma Pharmaceutical USD 1000K 22M 2022-12
Lonza CHF 1.7B 359M 2023-06
Pfizer USD 3.15B 516M 2023-09
Philips EUR 1.16B 195M 2023-09
Recordati EUR 302.28M 226.29M 2023-09
Regeneron Pharmaceuticals USD 16.24B 14.09B 2023-12
Roche Holding CHF 3.72B 1.27B 2023-06
UCB EUR 457M 442M 2023-06



Novartis Kontanter Og Tilsvarende - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Apr 2024.